Minimizing the risk of recurrent or progressive invasive mold infections during stem cell transplantation or further intensive chemotherapy.

about

Introducing mediterranean journal of hematology and infectious diseases.A risk prediction score for invasive mold disease in patients with hematological malignancies Hematopoietic stem cell transplantation in a very high risk group of patients with the support of granulocyte transfusion.

P2860

Q30484888-ADB6F6E2-CFFD-4979-B3DA-7C567426BEE5 Q35005712-A528A9A1-1755-44CA-BC3E-E912F5679D35 Q42867046-90DA6449-4A4C-45FF-9B40-39DC8E9A749C

P2860

Minimizing the risk of recurrent or progressive invasive mold infections during stem cell transplantation or further intensive chemotherapy.

Item

http://www.wikidata.org/entity/Q36867435

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Minimizing the risk of recurre ...... urther intensive chemotherapy.

@en

type

Item

label

Minimizing the risk of recurre ...... urther intensive chemotherapy.

@en

prefLabel

Minimizing the risk of recurre ...... urther intensive chemotherapy.

@en

P1476

Minimizing the risk of recurre ...... further intensive chemotherapy

@en

P2093

Grigg A

http://www.w3.org/2001/XMLSchema#string

P2860

Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia

Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials.

Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group.

Practice guidelines for lipid-based amphotericin B in stem cell transplant recipients.

Cost effectiveness of day 5 G-CSF (Lenograstim) administration after PBSC transplantation: results of a SFGM-TC randomised trial.

Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation.

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease.

Impact of the intensity of the pretransplantation conditioning regimen in patients with prior invasive aspergillosis undergoing allogeneic hematopoietic stem cell transplantation: A retrospective survey of the Infectious Diseases Working Party of th

Immune reconstitution following stem cell transplantation.

P304

3-12

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1399-3062.2007.00259.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Monica Slavin

P577

2007-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17605732

http://www.w3.org/2001/XMLSchema#string

Minimizing the risk of recurrent or progressive invasive mold infections during stem cell transplantation or further intensive chemotherapy.

about

P2860

P2860

Minimizing the risk of recurrent or progressive invasive mold infections during stem cell transplantation or further intensive chemotherapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698